Immunosuppressants: West Nile virus encephalitis, status epilepticus and West Nile pneumonia (first report for daclizumab): case report

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1176, 2007-01, pp. : 17-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mycophenolate mofetil: First report of West Nile virus infection: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1037, 2005-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Immunosuppressants: Epstein-Barr virus infection (first report for daclizumab) and leiomyosarcomas (first report for daclizumab, mycophenolate mofetil, sirolimus and tacrolimus): case report

By  

Reactions Weekly, Vol. 1, Iss. 1173, 2007-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Fludarabine/rituximab: False negative West Nile virus serology results: case report

By  

Reactions Weekly, Vol. 1, Iss. 1137, 2007-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

West Nile Virus Vaccine.

By  

Current Drug Targets - Infectious Disorders, Vol. 1, Iss. 1, 2001-05 ,pp. : 37-50

Bentham Science Publishers

Access to resources Recommend Favorite

Novel ‘‘pseudoinfectious’’ vaccines produced against West Nile and Japanese encephalitis virus

By  

Future Virology, Vol. 3, Iss. 4, 2008-07 ,pp. : 307-309

Future Medicine

Access to resources Recommend Favorite